Ondine Biomedical Share Discussion Threads

[jailbird] 24/9/2024 09:07

Market will dilute them at 2p, and I guess the CEo does not want to dilute here holdings away, knows the market are crooks

[smackeraim] 24/9/2024 08:44

it's the second premium placing this year. if they find it so easy to raise private capital, why do they need the market? food for thought maybe

[typo56] 24/9/2024 07:30

22,222,222 * 12.5p = £2.778m, therefore looks correct .... 12.5 pence.

[jailbird] 24/9/2024 07:29

big gap up by MMs in the morning, and mugs bought in

[jailbird] 24/9/2024 07:28

got mugged

[glavey] 24/9/2024 07:27

Pinch of salt required?

[bamboo2] 24/9/2024 07:07

Ondine secures C$5 million financing



All references to C$ in this announcement are to Canadian Dollars.

This Announcement uses a C$:£ exchange rate of 1 : 0.555041 as at 16:30 (GMT) on 23 September 2024.



Ondine Biomedical Inc. (LON: OBI), a Canadian life sciences company pioneering light-activated antimicrobial treatments, announces that it has agreed to a private placement financing in exchange for common shares from a new third-party private investor in Canada to support commercial growth (the "Private Placement").



The Company has agreed to issue 22,222,222 new common shares of no par value in the capital of the Company ("New Common Shares"), raising C$5 million (circa £2.8 million) at an issue price of 12.5 pence per New Common Share. The New Common Shares to be issued pursuant to the Private Placement will represent approximately 7.4 per cent. of the share capital of the Company as enlarged by the Private Placement. The closing of the transaction is expected to be on or before 8 November 2024. Application for admission of the New Common Shares and a further announcement will take place in due course.



The proceeds from the Private Placement will be used for general working capital purposes and to support commercial growth.



CEO Carolyn Cross stated; "Following our recent announcement of our distribution partnership with Mölnlycke Health Care, a world-leading MedTech company that specializes in innovative solutions for wound care and surgical procedures, we are pleased to have this additional capital in support of our expected sales growth."

[babbler] 24/9/2024 06:32

Is that a typo? 12.5p?

[purple11] 15/8/2024 16:42

5p placing

buy @5p

sell at 7p

[jailbird] 15/8/2024 14:30

I told you all before without decent revenues and profits , it will continue to burn cash The company has not indicated when that may be Matter of time before a big fish will come in to buy this , but hopefully not too cheaply

[purple11] 15/8/2024 14:23

it may be going alot lower

[purple11] 15/8/2024 14:22

moving down as predicted

[purple11] 11/8/2024 18:37

EVEN IF THEY PLACED AT A PREMIUM I WOULDNT BE IN A HURRY TO GET IN HERE

WAIT FOR A CLEAR UPTREND BEFORE ENTERING GLA

[premium beeks] 11/8/2024 18:33

Nice try chumps. I flogged mine that I got on the date of the last placing after there's was no follow through.But hey, keep following me around , keeps you off the streets I suppose.

[purple11] 11/8/2024 18:28

placing at 5p again?


it may drift down there like it did before once they arrange it

AVOID ATB

[purple11] 11/8/2024 18:14

AVOID

1p

[z1co] 06/8/2024 06:40

Another placing is due very soon before the US trials which now delayed by over 6 months

[premium beeks] 06/8/2024 06:37

Pre market looking excellent. Not that it matters a jot as I've had these since the last placing and not intending to flog